Pulmonary embolism in patients with dyspnea after COVID-19 infection

Basit Öğe Kaydı
dc.contributor.authorEKICI, A.
dc.contributor.authorEKICI, M.
dc.contributor.authorBACCIOGLU, A.
dc.contributor.authorINANC, F. A. K. Y. U. Z.
dc.contributor.authorASLAN, H.
dc.date.accessioned2025-01-21T16:43:50Z
dc.date.available2025-01-21T16:43:50Z
dc.date.issued2022
dc.departmentKırıkkale Üniversitesi
dc.description.abstractOBJECTIVE: Pulmonary embolism as a potential complication that may occur late in the course of COVID-19 cases. The aim of our study is to evaluate the frequency of pulmonary embolism in patients with new or ongoing dyspnea after a COVID-19 infection. PATIENTS AND METHODS: This is a single-center, prospective observational study to evaluate the clinical and radiological outcomes of consecutive patients presenting outpatient clinic diseases to the chest and a new or ongoing dyspnea after a COVID-19 infection. Demographic, clinical and laboratory data were collected. Dyspnea was evaluated according to the New York Heart Association (NYHA) classification. RESULTS: Pulmonary embolism was detected in 23.8% (25/105) of patients with new or ongoing dyspnea after a COVID-19 infection. Proportion of pulmonary embolism in patients with NYHA classes I, II, III and IV were respectively 8.7%, 20.0%. 30.0% and 35.3% (p for trend=0.02). Compared to NYHA class I and II patients with dyspnea. those in NYHA classes III and IV showed a higher rate of pulmonary embolism [31.6% vs. 14.6%. OR: 2.7 (1.0 to 7.1). p=0.04. respectively]. In Logistic Procedures. NYHA classes of dyspnea (OR: 4.3, 95% CI: 1.2 to 16.6, p=0.03) (NYHA class III and IV vs. NYHA class I and II) determine the likelihood of pulmonary embolism after COVID-19 infection. CONCLUSIONS: Pulmonary embolism is common in patients with new or ongoing shortness of breath after a COVID-19 infection. Pulmonary embolism is more likely to develop in patients with higher NYHA classes.
dc.identifier.endpage3759
dc.identifier.issn1128-3602
dc.identifier.issue10
dc.identifier.pmid35647858
dc.identifier.scopus2-s2.0-85131226559
dc.identifier.scopusqualityQ2
dc.identifier.startpage3751
dc.identifier.urihttps://hdl.handle.net/20.500.12587/25342
dc.identifier.volume26
dc.identifier.wosWOS:000809239500041
dc.identifier.wosqualityQ2
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherVerduci Publisher
dc.relation.ispartofEuropean Review For Medical and Pharmacological Sciences
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_20241229
dc.subjectCOVID-19 infection; Pulmonary embolism; New York Heart Association Classes
dc.titlePulmonary embolism in patients with dyspnea after COVID-19 infection
dc.typeArticle

Dosyalar

Koleksiyon

WOS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu